Buchumschlag

Prospective Pilot Study of Second Primary Tumor Prevention With Erlotinib and Celecoxib in Early‐Stage Squamous Cell Carcinoma of the Head and Neck: Long‐Term Follow‐Up

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Pauline Kim, Nabil F. Saba, Ashley McCook‐Veal, Yuan Liu, Adam M. Klein, Jonathan J. Beitler, Amy Chen, Fadlo R. Khuri, Dong M. Shin
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Head & Neck
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
von: Aarti Bhatia, et al.
Veröffentlicht: (2025)

Correction to “Snail Controls the Mesenchymal Phenotype and Drives Erlotinib Resistance in Oral Epithelial and Head and Neck Squamous Cell Carcinoma Cells”
Veröffentlicht: (2024)

Examining the Interaction Between Sex and Race in Outcomes of Head and Neck Squamous Cell Carcinoma
von: Geena Jung, et al.
Veröffentlicht: (2025)

Efficacy of Multimodal Work‐Up of Head and Neck Squamous Cell Carcinoma Lymph Node Metastasis of Unknown Primary
von: Robin W. Jansen, et al.
Veröffentlicht: (2025)

Aggressive Head and Neck Squamous Cell Carcinoma in the Setting of GATA2 Deficiency
von: Brejjette Aljabi, et al.
Veröffentlicht: (2025)

Association of Socioeconomic Factors and Immunotherapy in Cutaneous Squamous Cell Carcinoma of the Head and Neck
von: Christie Hung, et al.
Veröffentlicht: (2026)

Cigarette Smoke Exposure Attenuates T2R ‐Mediated Apoptosis in Head and Neck Squamous Cell Carcinoma
von: Kyle Polen, et al.
Veröffentlicht: (2026)

Recurrence Patterns of Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
von: Nikhil Bellamkonda, et al.
Veröffentlicht: (2024)

Impact of Extranodal Extension in Patients With Regional Metastases of Head and Neck Cutaneous Squamous Cell Carcinoma
von: Rachel Braude, et al.
Veröffentlicht: (2026)

Aberrant Splicing Burden Predicts Immune Infiltration and Prognosis in Head and Neck Squamous Cell Carcinomas
von: Sandhya Kalavacherla, et al.
Veröffentlicht: (2025)

Impact of Prior Neck Treatment Status on Salvage Treatment Outcomes in Isolated Regional Recurrence of Head and Neck Squamous Cell Carcinoma
von: Younghac Kim, et al.
Veröffentlicht: (2025)

The Role of Multicancer Early Detection Tests in Head and Neck Squamous Cell Carcinoma: A Case Series
von: Abhinav Talwar, et al.
Veröffentlicht: (2026)

History of Head and Neck Cancer as a Predictor of Recurrence and Second Primary Tumors After Transoral Videolaryngoscopic Surgery in Patients With Hypopharyngeal Squamous Cell Carcinoma
von: Mitsuhiko Katoh, et al.
Veröffentlicht: (2026)

The Prognostication of Surgically Resected Head and Neck Squamous Cell Carcinoma Using Pre‐Therapy Neutrophil and Lymphocyte Counts
von: Pranit R. Sunkara, et al.
Veröffentlicht: (2024)

Risk Factors for Progressive Disease After Immune Checkpoint Inhibitor Therapy in Head and Neck Squamous Cell Carcinoma
von: Seo Yoon Jang, et al.
Veröffentlicht: (2025)

Survival Impact of Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma: A National Cancer Database Analysis
von: Rohan Vuppala, et al.
Veröffentlicht: (2025)

Detection of Circulating Cancer‐Associated Fibroblasts in Head and Neck Squamous Cell Carcinoma and Their Impact on Circulating Tumor Cells
von: Kazuaki Chikamatsu, et al.
Veröffentlicht: (2025)

Hypoxia and Oxidation Pathway Crosstalk in Head and Neck Squamous Cell Carcinoma
von: Abdullah A. Adil, et al.
Veröffentlicht: (2026)

Altered Bacteria Abundance Is Associated With Outcomes in Head and Neck Squamous Cell Carcinoma
von: Delaney H. Sheehan, et al.
Veröffentlicht: (2025)

Impact of Extranodal Extension in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Systematic Review and Meta‐Analysis
von: Andrea Costantino, et al.
Veröffentlicht: (2025)

The Burden of Recurrent Head and Neck Squamous Cell Carcinoma Across the United Kingdom: Results From a National Snapshot Study
von: Andrew Williamson, et al.
Veröffentlicht: (2024)

Prognosis After Discontinued Treatment due to Immune‐Related Adverse Events in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
von: Hiromasa Ishihara, et al.
Veröffentlicht: (2025)

Exploratory Biomarker Analysis of Abemaciclib in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma With Dysregulated CDK4 /6 Pathway
von: Joo‐Hwan Park, et al.
Veröffentlicht: (2026)

First‐Line Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective, Multicenter, Real‐World Study
von: Alizée Simon, et al.
Veröffentlicht: (2025)

Safety and Efficacy of Intra‐Arterial Chemotherapy Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma
von: Chao Yang, et al.
Veröffentlicht: (2025)

Safety and Efficacy Findings From a Phase Ib/ II Study of ASP ‐1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
von: David M. Cognetti, et al.
Veröffentlicht: (2025)

Early and Long‐Term Thyroid Dysfunction in Patients With Head and Neck Squamous Cell Carcinoma After External Radiotherapy: Clinicopathological Risk Factors
von: Adriana Russo Fiore, et al.
Veröffentlicht: (2025)

Variations in Treatment Prescription and Survival Outcomes Between Older and Younger Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Radiotherapy
von: Farhannah Aly, et al.
Veröffentlicht: (2026)

Prediction and Prognostication of Peripheral Blood Biomarkers in Head and Neck Cutaneous Squamous Cell Carcinoma
von: Mikayla G. Hubbard, et al.
Veröffentlicht: (2026)

A Comprehensive Immune Checkpoint Phenotype Predicts Response and Survival to PD ‐1 Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
von: Mathias Fiedler, et al.
Veröffentlicht: (2026)

Efficacy and Failure Patterns Following Target Volume and Dose Reduction After Neoadjuvant Therapy in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
von: Xiong Zhou, et al.
Veröffentlicht: (2024)

Prognosis and Phenotypes of Advanced Head and Neck Carcinoma Associated With Hypercalcemia
von: Elodie Mamou, et al.
Veröffentlicht: (2025)

Oncological Outcomes of Salvage Oropharyngectomy in Irradiated Neck for Recurrent or Metachronous Squamous Cell Carcinoma
von: Jade Saykaly, et al.
Veröffentlicht: (2026)

Bilateral Neck Dissection in cN0 Supraglottic Squamous Cell Carcinoma: Essential or Not?
von: Jiamei Wen, et al.
Veröffentlicht: (2025)

Expiratory Muscle Strength Training in Head and Neck Cancer Survivors With Radiation‐Associated Dysphagia: Results of a Pilot Prospective Trial
von: Beatrice Manduchi, et al.
Veröffentlicht: (2026)

CRISPR Screens Identify PIK3C2A as a Novel Mediator of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma
von: Jiayu Wang, et al.
Veröffentlicht: (2025)

EpCAM‐Targeted Erlotinib Delivery: Enhancing Nasopharyngeal Carcinoma Treatment With Polyethylene Glycol‐Coated Graphene Oxide
von: Chien‐Fu Yeh, et al.
Veröffentlicht: (2025)

Mohs Micrographic Surgery Efficacy for Solid Organ Transplant Head and Neck Cutaneous Squamous Cell Carcinoma
von: Kevin L. Li, et al.
Veröffentlicht: (2025)

Response to Letter to the Editor: Fully COVID ‐19 Vaccinated Status Enhanced the Efficacy of Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
von: Chien‐Chung Wang, et al.
Veröffentlicht: (2026)

Postoperative Radiotherapy for Head and Neck Merkel Cell Carcinoma: Sometimes, Less Is More
von: Yuan Zheng, et al.
Veröffentlicht: (2025)